Rapid Micro Biosystems (NASDAQ:RPID) Lowered to Sell Rating by Wall Street Zen

Rapid Micro Biosystems (NASDAQ:RPID) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Sunday.

A number of other brokerages have also recently commented on RPID. Weiss Ratings reiterated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Wednesday, October 8th. Lake Street Capital assumed coverage on shares of Rapid Micro Biosystems in a research note on Monday, July 28th. They issued a “buy” rating and a $8.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $8.00.

Rapid Micro Biosystems Stock Performance

Shares of RPID opened at $4.21 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.41 and a current ratio of 4.23. The stock has a 50 day moving average price of $3.21 and a two-hundred day moving average price of $3.20. Rapid Micro Biosystems has a 52 week low of $0.87 and a 52 week high of $4.50. The firm has a market capitalization of $186.59 million, a P/E ratio of -4.17 and a beta of 1.37.

Rapid Micro Biosystems (NASDAQ:RPID) last issued its earnings results on Friday, November 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.26). The firm had revenue of $7.84 million for the quarter, compared to analyst estimates of $7.60 million. Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%. Rapid Micro Biosystems has set its FY 2025 guidance at EPS. Equities analysts forecast that Rapid Micro Biosystems will post -1.1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC increased its position in Rapid Micro Biosystems by 1.6% during the 2nd quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock worth $704,000 after purchasing an additional 3,143 shares in the last quarter. American Century Companies Inc. lifted its holdings in shares of Rapid Micro Biosystems by 46.1% in the second quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock valued at $58,000 after buying an additional 5,341 shares during the period. Dimensional Fund Advisors LP grew its position in Rapid Micro Biosystems by 37.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock worth $186,000 after purchasing an additional 15,255 shares in the last quarter. Legato Capital Management LLC bought a new stake in Rapid Micro Biosystems in the first quarter worth approximately $41,000. Finally, XTX Topco Ltd bought a new stake in shares of Rapid Micro Biosystems during the 2nd quarter worth $144,000. 52.60% of the stock is currently owned by hedge funds and other institutional investors.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.